US FDA approves "grandfathered" oxycodone products

The US FDA has approved new drug applications (NDAs) for a line of controlled substance products containing oxycodone hydrochloride, said partners Lehigh Valley Technologies (LVT) and Glenmark Generics Inc, a US subsidiary of the Indian firm Glenmark.